BeStock  

Amphastar Pharmaceuticals AMPH

$25.54 −$0.37 (-1.43%)
Market closed · Oct 8, 7:20 am ET · Last extended-hours $25.54 0.00%
Open$25.91
Prev close$25.91
Day range$25.29 – $26.17
Volume776.3K
Market cap$1.09B
P/E (TTM)15.1
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$183.90M+5.4% YoY
Operating profit$39.73M-5.8% YoY
Net profit$30.35M-2.2% YoY
Diluted EPS$0.67+4.7% YoY
Free cash flow$42.73M+87.6% YoY
Operating cash flow$51.32M

Revenue, last 8 quarters

$191.2MSep '24$186.5MDec '24$170.5MMar '25$174.4MJun '25$191.8MSep '25$183.1MDec '25$171.2MMar '26$183.9MJun '26

Net profit, last 8 quarters

$40.4MSep '24$38.0MDec '24$25.3MMar '25$31.0MJun '25$17.4MSep '25$24.4MDec '25$6.4MMar '26$30.3MJun '26

Diluted EPS by quarter

0.78Sep '240.74Dec '240.51Mar '250.64Jun '250.37Sep '250.51Dec '250.14Mar '260.67Jun '26

Free cash flow by quarter

$46.2MSep '24$16.6MDec '24$24.4MMar '25$22.8MJun '25$47.2MSep '25$24.6MDec '25$38.3MMar '26$42.7MJun '26

Annual revenue

$349.8MFY20$437.8MFY21$499.0MFY22$644.4MFY23$732.0MFY24$719.9MFY25

Profitability & balance sheet

Gross margin47.7%
Operating margin15.7%
Net margin10.8%
Return on equity10.3%
Return on assets4.7%
Return on invested capital6.4%
Current ratio2.40
Liabilities / assets55.9%
Cash & investments$290.12M
Total debt$679.52M
Net cash (debt)-$389.40M
Free cash flow / sales20.9%

Where the revenue comes from

Quarter 2026/Q2

By business line

  • Other products$66.19M 36.0%
  • BAQSIMI$45.50M 24.7%
  • Primatene MIST$21.00M 11.4%
  • Epinephrine$15.85M 8.6%
  • Lidocaine$15.04M 8.2%
  • Glucagon$11.91M 6.5%
  • Ipratropium bromide$8.41M 4.6%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $183.90M $171.17M $719.89M $183.11M $191.84M
Total Operating Revenue $183.90M $171.17M $719.89M $183.11M $191.84M
Cost of Revenue $90.43M $100.85M $363.83M $97.44M $93.19M
Gross Profit $93.47M $70.32M $356.06M $85.67M $98.65M
Operating Expense $53.74M $56.69M $215.65M $50.06M $73.33M
Selling and Admin Expenses $31.58M $29.96M $129.81M $26.75M $50.97M
-Selling & Marketing Expense $13.34M $11.93M $43.89M $10.28M $11.51M
-General & Admin Expense $18.24M $18.03M $85.93M $16.47M $39.47M
Research & Development $22.16M $26.74M $85.84M $23.31M $22.35M
Operating Profit $39.73M $13.63M $140.40M $35.61M $25.32M
Net Non-Operating Interest Income (Expense) -$4.37M -$4.15M -$16.80M -$4.21M -$4.04M
Non-Operating Interest Income $2.29M $2.40M $8.68M $2.42M $2.25M
Non-Operating Interest Expense $6.66M $6.55M $25.48M $6.63M $6.28M
Other Income (Expense) $3.19M $575,000.00 $23,000.00 $515,000.00 $231,000.00
Other Non-Operating Income (Expenses) $3.19M $575,000.00 $23,000.00 $515,000.00 $231,000.00
Pretax Profit $38.54M $10.05M $123.62M $31.91M $21.51M
Tax $8.20M $3.63M $25.53M $7.49M $4.16M
Net Profit $30.35M $6.42M $98.09M $24.43M $17.35M
Profit from Continuing Operations $30.35M $6.42M $98.09M $24.43M $17.35M
Net Income to Parent Company $30.35M $6.42M $98.09M $24.43M $17.35M
Net Income to Common Stockholders $30.35M $6.42M $98.09M $24.43M $17.35M
Basic EPS $0.69 $0.14 $2.10 $0.53 $0.38
Diluted EPS $0.67 $0.14 $2.03 $0.51 $0.37
Earnings from Equity Interest Net of Tax – – $0.00 $0.00 $0.00

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $1.74B $1.65B $1.63B $1.63B $1.67B
Total Current Assets $630.95M $633.68M $636.02M $636.02M $639.47M
Cash and Cash Equivalents & Short-Term Investments $290.12M $291.95M $282.81M $282.81M $276.21M
-Cash and Cash Equivalents $223.61M $170.94M $170.18M $170.18M $216.27M
-Short Term Investments $66.51M $121.01M $112.64M $112.64M $59.94M
Receivables $147.49M $157.45M $160.73M $160.73M $148.87M
-Accounts Receivable $144.86M $147.85M $143.56M $143.56M $146.81M
-Taxes Receivable $2.63M $9.61M $17.17M $17.17M $2.07M
Inventory $179.91M $170.19M $176.89M $176.89M $185.93M
Restricted Cash $2.44M $2.44M $2.44M $2.44M $2.44M
Other Current Assets $11.00M $11.65M $13.15M $13.15M $26.02M
Total Non-Current Assets $1.11B $1.01B $993.28M $993.28M $1.03B
Net PPE $389.13M $378.91M $353.72M $353.72M $353.53M
-Gross PPE $710.35M $692.28M $659.99M $659.99M $651.82M
-Accumulated Depreciation -$321.22M -$313.37M -$306.27M -$306.27M -$298.29M
Goodwill and Other Intangible Assets $647.83M $559.62M $565.97M $565.97M $572.24M
-Goodwill $3.31M $3.33M $3.40M $3.40M $3.40M
-Other Intangible Assets $644.52M $556.29M $562.56M $562.56M $568.83M
Non-Current Deferred Assets $42.46M $42.46M $42.46M $42.46M $71.12M
Other Non-Current Assets $33.39M $33.48M $31.14M $31.14M $29.87M
Total Liabilities $975.61M $874.77M $840.49M $840.49M $889.48M
Total Current Liabilities $263.21M $164.48M $158.16M $158.16M $205.23M
Payables $29.47M $35.91M $32.83M $32.83M $46.17M
-Accounts Payable $28.93M $35.50M $32.59M $32.59M $40.54M
-Total Tax Payable $546,000.00 $414,000.00 $239,000.00 $239,000.00 $5.63M
Current Accrued Expenses $222.44M $117.19M $115.76M $115.76M $150.30M
Short-Term Debt and Capital Lease Obligation $11.29M $11.38M $9.57M $9.57M $8.75M
-Current Debt $2.49M $1.67M $1.64M $1.64M $923,000.00
-Current Capital Lease Obligation $8.80M $9.71M $7.93M $7.93M $7.83M
Total Non-Current Liabilities $712.40M $710.29M $682.34M $682.34M $684.25M
Long Term Debt and Capital Lease Obligation $677.03M $675.00M $646.43M $646.43M $648.02M
-Long Term Debt $609.56M $609.80M $608.75M $608.75M $608.58M
-Long Term Capital Lease Obligation $67.47M $65.20M $37.68M $37.68M $39.44M
Non-Current Deferred Liabilities $5.93M $5.93M $5.93M $5.93M $6.96M
Other Non-Current Liabilities $29.44M $29.37M $29.98M $29.98M $29.27M
Total Equity $768.16M $773.39M $788.81M $788.81M $776.75M
Stockholders' Equity $768.16M $773.39M $788.81M $788.81M $776.75M
Capital Stock $6,000.00 $6,000.00 $6,000.00 $6,000.00 $6,000.00
-Common Stock $6,000.00 $6,000.00 $6,000.00 $6,000.00 $6,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $553.00M $543.82M $535.38M $535.38M $527.22M
Retained Earnings $703.65M $673.30M $666.88M $666.88M $642.45M
Less: Treasury Stock $482.60M $438.00M $408.15M $408.15M $387.65M
Gains/Losses Not Affecting Retained Earnings -$5.90M -$5.74M -$5.31M -$5.31M -$5.27M
Investments and Advances – – $0.00 $0.00 $0.00

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $51.32M $47.84M $156.12M $32.86M $52.58M
Net cash flow from continuing operations $51.32M $47.84M $156.12M $32.86M $52.58M
Net Income from Continuing Operations $30.35M $6.42M $98.09M $24.43M $17.35M
Gain/Loss from Continuing Operations -$870,000.00 -$412,000.00 $2.53M $477,000.00 $286,000.00
Depreciation & Depletion & Amortization $16.46M $16.49M $63.20M $15.99M $15.77M
Other Non-Cash Items $875,000.00 $761,000.00 $3.36M $866,000.00 $885,000.00
Change in Working Capital -$2.58M $15.31M -$65.97M -$42.73M $12.00M
-Change in Receivables $2.98M -$4.55M -$6.37M $3.23M -$13.79M
-Change in Inventory -$9.88M $6.25M -$21.06M $9.01M $5.86M
-Change in Prepaid Assets -$2.54M -$2.33M -$3.53M $9.83M -$7.94M
-Change in Payables and Accrued Expense $1.96M $9.60M -$4.56M -$42.64M $25.34M
-Change in Other Current Liabilities -$2.20M -$1.42M -$5.61M -$1.66M -$1.59M
-Change In Other Working Capital $7.11M $7.74M -$24.84M -$20.50M $4.12M
Net cash flow from investing $44.87M -$16.73M -$70.33M -$60.57M -$19.62M
Net Cash Flow from Continuing Investing Activities $44.87M -$16.73M -$70.33M -$60.57M -$19.62M
Net PPE Purchase and Sale -$8.59M -$9.51M -$34.88M -$8.27M -$5.35M
Net Investment Purchase and Sale $55.26M -$7.23M -$28.84M -$51.86M -$12.68M
Financing Cash Flow -$43.54M -$30.21M -$67.43M -$18.37M -$4.35M
Net Cash Flow from Continuing Financing Activities -$43.54M -$30.21M -$67.43M -$18.37M -$4.35M
Net Issuance Payments Of Debt -$525,000.00 -$29,000.00 $5.99M $169,000.00 $128,000.00
Net Common Stock Issuance -$45.21M -$29.49M -$75.59M -$20.52M -$4.85M
Proceeds from Stock Option Exercised $2.20M -$686,000.00 $2.86M $1.98M $379,000.00
Ending Cash Balance $223.85M $171.17M $170.41M $170.41M $216.50M
Net Change in Cash $52.66M $900,000.00 $18.36M -$46.08M $28.62M
Beginning Cash Balance $171.17M $170.41M $151.84M $216.50M $187.92M
Effect of Exchange Rate Changes $16,000.00 -$138,000.00 $210,000.00 -$9,000.00 -$41,000.00
Free Cash Flow $42.73M $38.33M $118.98M $24.59M $47.24M
Deferred Tax – – $27.63M – –
Net Intangibles Purchase and Sale – – -$2.25M $0.00 $0.00
Net Business Purchase and Sale – – $0.00 $0.00 –
Net Other Investing Changes – – -$4.36M -$434,000.00 -$1.59M
Net Other Financing Charges – – -$687,000.00 -$8,000.00 -$4,000.00

Discussion

No comments yet — be the first to weigh in on AMPH.

Leave a comment

Scroll to Top